Please assess the completion status of the following clinical trial:

Trial Title: Injection Pressure & Adductor Canal Block

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~1. Planned general anesthetic.~2. American Society of Anesthesia classes I, II, or III.~3. Patients aged 18-65.~4. English-speaking patients.~Exclusion criteria:~1. ASA classes IV and V.~2. Patients younger than 18 or older than 65.~3. Contraindication to regional anesthesia (coagulopathy, patient refusal).~4. Allergy to local anesthetic or other study medications.~5. BMI \> 35 kg/m2.~6. Chronic opioid use (daily or almost daily use for \> 3 months).~7. Active illicit drug use.~8. Additional surgical site other than the limb for adductor canal block.~9. Pregnancy.~10. Preexisting neuropathy in the operative limb.~11. Inability to communicate to investigators or hospital staff.~12. Inability to speak or understand English.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- High Pressure (Type: EXPERIMENTAL): High pressure injection of Ropivacaine local anesthetic at greater than 20 psi
- Low Pressure (Type: ACTIVE_COMPARATOR): Low pressure injection of Ropivacaine local anesthetic at less than 15 psi

Based on this trial design, predict the completion outcome and termination type (if applicable).